![Tenofovir DF Monotherapy is Superior to Entecavir-Adefovir Combination in Chronic Hepatitis B Patients who Are Suboptimal Responder for Lamivudine-Adefovir Therapy with RT204I/V Mutation: A Interim Analysis of Prospective Multicenter Trial]()
Tenofovir DF Monotherapy is Superior to Entecavir-Adefovir Combination in Chronic Hepatitis B Patients who Are Suboptimal Responder for Lamivudine-Adefovir Therapy with RT204I/V Mutation: A Interim Analysis of Prospective Multicenter TrialKim, H.S.; Lee, S.H.; Kim, S.G.; Kim, Y.S.; Jeong, S.W.; Jang, J.Y.; Kim, B.S.; Won Jun, D.; Kim, T.Y.; Sohn, J.H.; Kim, Y.D.; Cheon, G.J.; Lee, B.S. · Journal of Hepatology · 2016